Researchers have identified a method to enhance the effectiveness of a promising cancer treatment. They found that modifying ...
Adding a new indication for the CAR T cell therapy could help BMS offset the loss-of-exclusivity headwinds it faces in the ...
Fate Therapeutics uses iPSC and gene editing to offer scalable off-the-shelf therapies. Read more to see why I rate FATE ...
The FDA has granted Fast Track designation to ADI-001 for the treatment of refractory systemic lupus erythematosus with extrarenal involvement.
Researchers have revolutionized cancer immunotherapy by developing a way to grow T cells in the lab that live longer and ...
Pancreatic cancer patients may benefit from future precision treatments as a new study shows how some tumours may potentially be more susceptible to macrophage-based therapies, and clues behind why ...
After a nearly $300 million IPO little more than a year ago, a young Peninsula biotech company will discontinue what had been ...
A new advance may make it possible to use off-the-shelf CAR T cells provided by healthy donors. The new approach studied in mice equipped CAR T cells with the viral protein Nef.